Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain, Postoperative 5Breast Neoplasms 3Thyroid Neoplasms 2Chronic Pain 2Brain Neoplasms 2Agnosia 2Urinary Bladder Neoplasms 1Thrombosis 1Sleep Initiation and Maintenance Disorders 1Sigmoid Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pain 1Opioid Consumption, Postoperative 1Neuroinflammatory Diseases 1Meningioma 1Lung Injury 1Inflammation 1Hypoxia 1Hyperthyroidism 1Goiter 1Elderly 1Delirium 1Colorectal Neoplasms 1Breast Cancer Female 1Abdominal Cancer Surgeries 1

Interventions

fluoroazomycin arabinoside 2Propofol 2pimonidazole 1Tirapazamine 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Magnetic Resonance Imaging 1Ketamine 1Ethiodized Oil 1Dexmedetomidine 1Blood Specimen Collection 1Alfentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypoxia × Dexmedetomidine × 1 year × Clear all
NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Aristotle University Of Thessaloniki

Phase 4 Completed
56 enrolled
CNS

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡